Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Health Catalyst to Participate in Upcoming Investor Conferences
-
Colibri Provides Summary of Over-Subscribed Non-Brokered Private Placement
-
Mindy Connor Joins Real Broker, LLC and Launches New Website
-
Logitech Cybersecurity Disclosure
-
Banzai Reports Third Quarter 2025 Financial Results
-
Healthy Extracts Reports Record Q3 2025, with Revenue up 23%
-
Insight Digital Partners II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about November 18, 2025
-
Cineverse Reports Second Quarter Fiscal Year 2026 Results
-
Reviver Appoints Andrew Iorgulescu as CEO, Signaling a New Era of Growth and Automotive Innovation
-
Triumph to Present at the Stephens Annual Investment Conference on November 18, in Nashville, Tennessee
-
Stinger Resources Inc. Announces Cancellation of Incentive Stock Options
-
From ASX to Louisiana: How Tech Thinking Transforms Traditional Real Estate
-
Morris County Agent Reports Strong Fall Market Performance Despite Seasonal Expectations
-
TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives
-
Mawson Infrastructure Group Inc. Reports Third Quarter 2025 Financial Results
-
Quantum Computing Inc. Reports Third Quarter 2025 Financial Results
-
Modiv Industrial Announces Third Quarter 2025 Results
-
URBAN ONE, INC. ANNOUNCES OFFERS AND CONSENT SOLICITATION
-
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
-
Pennsylvania American Water Files Rate Request Driven by More Than $1.2 Billion in Ongoing Investment to Provide Safe, Clean, Reliable Service
-
Powerfleet to Attend Fall New York 2025 Investor Conferences
-
First Merchants Corporation Announces Cash Dividend
-
InTest Corporation to Present at the 17th Annual Southwest Ideas Conference
-
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Strive, Inc. Announces Third Quarter 2025 Financial Results
-
Taitron Announces Voluntary Nasdaq Delisting, CFO Resignation and Third Quarter 2025 Results
-
Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
-
Cohen & Steers Announces Changes to Realty Indexes
-
Gemini to Participate in Citi’s 14th Annual FinTech Conference
-
Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update
-
Materialise NV Announces Results of 2025 Extraordinary Shareholders’ Meeting
-
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
-
Capital Bancorp Appoints Jacob Dalaya as Chief Financial Officer
-
Dragonfly Energy Reports Third Quarter 2025 Results
-
Epsilon Announces the Closing of the Acquisitions of the Peak Companies With Assets in the Powder River Basin
-
Biogen Completes Acquisition of Alcyone Therapeutics
-
The Marketing Alliance Announces Financial Results for Fiscal Second Quarter Ended September 30, 2025
-
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
-
Coherent Introduces Axon FP – A Breakthrough Fiber-Delivered Femtosecond Laser for Multiphoton Microscopy
-
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
-
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
4DMT Announces New Employment Inducement Grants
-
Elvictor Group Reports Third Quarter 2025 Financial Results and Provides an Operational Update
-
Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates
-
The 11th Annual Generational Salute – A Tribute to Our Troops, Sponsored by Generational Group
-
/C O R R E C T I O N -- Mill City Press/
-
Nuvalent Announces Timing of Topline Pivotal Data for TKI Pre-treated Patients with Advanced ALK-positive NSCLC from ALKOVE-1 Clinical Trial of Neladalkib
-
Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
-
Trust Stamp announced filing its 10-Q for Q3-2025 reflecting 71% and 41% increases in Net Recognized Revenue compared to the corresponding three and nine month periods in 2024, and a 17% and 19% decre
-
Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity
